Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction



      Diabetes mellitus (diabetes) increases the risk of acute myocardial infarction, which can result in cardiogenic shock. Data on the relation of diabetes and the occurrence and prognosis of cardiogenic shock postacute myocardial infarction are scant.


      Among the National Inpatient Sample patients aged ≥18 years and hospitalized for acute myocardial infarction during the 2012-2014 period, we examined the association between diabetes and the incidence and outcomes of cardiogenic shock complicating acute myocardial infarction, using multivariable logistic and linear regression models.


      Of 1,332,530 hospitalizations for acute myocardial infarction, 72,765 (5.5%) were complicated by cardiogenic shock. In acute myocardial infarction patients, cardiogenic shock incidence was higher among those with vs without diabetes (5.8% vs 5.2%; adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI], 1.11-1.19; P < .001), with 42.8% (n = 31,135) of patients with acute myocardial infarction and cardiogenic shock having diabetes. Diabetic patients were less likely to undergo revascularization (percutaneous coronary intervention or coronary artery bypass grafting) (67.1% vs 68.7%; aOR 0.88; 95% CI, 0.80-0.96; P = .003). Diabetes was associated with higher in-hospital mortality in patients with acute myocardial infarction and cardiogenic shock (37.9% vs 36.8%; aOR 1.18; 95% CI, 1.09-1.28; P < .001). Among survivors, patients with diabetes had a longer hospital stay (mean ± SEM: 11.6 ± 0.16 vs 10.9 ± 0.16 days; adjusted estimate 1.12; 95% CI, 1.06-1.18; P < .001) and were more likely to be discharged to a skilled nursing home or with home health care (56.0% vs 50.5%; aOR 1.19; 95% CI, 1.07-1.33; P = .001).


      In a large cohort of acute myocardial infarction patients, preexisting diabetes was associated with an increased risk of cardiogenic shock and worse outcomes in those with cardiogenic shock.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Goldberg R.J.
        • Spencer F.A.
        • Gore J.M.
        • Lessard D.
        • Yarzebski J.
        Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction a population-based perspective.
        Circulation. 2009; 119: 1211-1219
        • Kolte D.
        • Khera S.
        • Aronow W.S.
        • et al.
        Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.
        J Am Heart Assoc. 2014; 3 (e000590)
        • Wayangankar S.A.
        • Bangalore S.
        • McCoy L.A.
        • et al.
        Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the cathpci registry.
        JACC Cardiovasc Interv. 2016; 9: 341-351
        • Hochman J.S.
        Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm.
        Circulation. 2003; 107: 2998-3002
        • Thiele H.
        • Allam B.
        • Chatellier G.
        • Schuler G.
        • Lafont A.
        Shock in acute myocardial infarction: The Cape Horn for trials?.
        Eur Heart J. 2010; 31: 1828-1835
        • Lindholm M.G.
        • Boesgaard S.
        • Torp-Pedersen C.
        • Kober L.
        Diabetes mellitus and cardiogenic shock in acute myocardial infarction.
        Eur J Heart Fail. 2005; 7: 834-839
        • Healthcare Cost and Utilization Project (HCUP)
        Overview of the National (Nationwide) Inpatient Sample (NIS).
        (Agency for Healthcare Research and Quality, Rockville, MD; Available at)
        Date accessed: January 12, 2018
        • Healthcare Cost and Utilization Project (HCUP)
        Trend Weights for HCUP NIS Data.
        (Agency for Healthcare Research and Quality, Rockville, MD; Available at)
        • Quan H.
        • Drosler S.
        • Sundararajan V.
        • et al.
        Adaptation of AHRQ patient safety indicators for use in ICD-10 administrative data by an international consortium.
        in: Advances in Patient Safety: New Directions and Alternative Approaches. Vol. 1: Assessment. Agency for Healthcare Research and Quality, Rockville, MD2008: 1-19
        • Lambert L.
        • Blais C.
        • Hamel D.
        • et al.
        Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data?.
        Can J Cardiol. 2012; 28: 162-168
        • Gupta T.
        • Harikrishnan P.
        • Kolte D.
        • et al.
        Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States.
        Am J Cardiol. 2015; 115: 1033-1041
        • Gupta T.
        • Kolte D.
        • Khera S.
        • et al.
        Smoker's paradox in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
        J Am Heart Assoc. 2016; 5 (e003370)
        • Healthcare Cost and Utilization Project (HCUP)
        HCUP CCS.
        (Agency for Healthcare Research and Quality, Rockville, MD; Available at) (Accessed January 12, 2018)
        • Khokhar B.
        • Jette N.
        • Metcalfe A.
        • et al.
        Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations.
        BMJ Open. 2016; 6 (e009952)
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        • Coffey R.M.
        Comorbidity measures for use with administrative data.
        Med Care. 1998; 36: 8-27
        • Khera R.
        • Angraal S.
        • Couch T.
        • et al.
        Adherence to methodological standards in research using the National Inpatient Sample.
        JAMA. 2017; 318: 2011-2018
        • Mamdani M.
        • Sykora K.
        • Li P.
        • et al.
        Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding.
        BMJ. 2005; 330: 960-962
        • Khazanie P.
        • Liang L.
        • Qualls L.G.
        • et al.
        Outcomes of medicare beneficiaries with heart failure and atrial fibrillation.
        JACC Heart Fail. 2014; 2: 41-48
        • Hernandez A.F.
        • Greiner M.A.
        • Fonarow G.C.
        • et al.
        Relationship between early physician follow-up and 30-day readmission among medicare beneficiaries hospitalized for heart failure.
        JAMA. 2010; 303: 1716-1722
        • Shindler D.M.
        • Palmeri S.T.
        • Antonelli T.A.
        • et al.
        Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry.
        J Am Coll Cardiol. 2000; 36: 1097-1103
        • Tedesco J.V.
        • Wright R.S.
        • Williams B.A.
        • et al.
        Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population.
        Mayo Clin Proc. 2003; 78: 561-566
        • Kunadian V.
        • Qiu W.
        • Ludman P.
        • et al.
        Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society).
        JACC Cardiovasc Interv. 2014; 7: 1374-1385
        • Gąsior M.
        • Pres D.
        • Gierlotka M.
        • et al.
        The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry.
        Kardiol Pol. 2012; 70: 1215-1224
        • Yang J.H.
        • Song P.S.
        • Song Y.B.
        • et al.
        Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
        Crit Care. 2013; 17: R218
        • Timmer J.R.
        • Hoekstra M.
        • Nijsten M.W.N.
        • et al.
        Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
        Circulation. 2011; 124: 704-711
        • Gregg E.W.
        • Sattar N.
        • Ali M.K.
        The changing face of diabetes complications.
        Lancet Diabetes Endocrinol. 2016; 4: 537-547
        • Alegria J.R.
        • Miller T.D.
        • Gibbons R.J.
        • Yi Q.-L.
        • Yusuf S.
        Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.
        Am Heart J. 2007; 154: 743-750
        • Bakth S.
        • Arena J.
        • Lee W.
        • et al.
        Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning.
        J Clin Invest. 1986; 77: 382-395
        • Movahed M.-R.
        • Hashemzadeh M.
        • Jamal M.
        Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus.
        Heart Vessels. 2007; 22: 251-253
        • Vinik A.I.
        • Maser R.E.
        • Mitchell B.D.
        • Freeman R.
        Diabetic autonomic neuropathy.
        Diabetes Care. 2003; 26: 1553-1579
        • Singh J.P.
        • Larson M.G.
        • O'Donnell C.J.
        • et al.
        Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).
        Am J Cardiol. 2000; 86: 309-312
        • Balcioğlu S.
        • Arslan U.
        • Türkoğlu S.
        • Ozdemir M.
        • Cengel A.
        Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy.
        Am J Cardiol. 2007; 100: 890-893
        • Iwakura K.
        • Ito H.
        • Ikushima M.
        • et al.
        Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.
        J Am Coll Cardiol. 2003; 41: 1-7
        • Anderson M.L.
        • Peterson E.D.
        • Peng S.A.
        • et al.
        Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification a report from NCDR.
        Circ Cardiovasc Qual Outcomes. 2013; 6: 708-715
        • Hochman J.S.
        • Sleeper L.A.
        • Webb J.G.
        • et al.
        Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
        JAMA. 2006; 295: 2511-2515
        • Menke A.
        • Casagrande S.
        • Geiss L.
        • Cowie C.C.
        Prevalence of and trends in diabetes among adults in the United States, 1988-2012.
        JAMA. 2015; 314: 1021-1029
        • Malmberg K.
        • Norhammar A.
        • Wedel H.
        • Rydén L.
        Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction (DIGAMI).
        Circulation. 1999; 99: 2626-2632